AdvaMed Asks U.S. Court of Appeals to Support a Fair and Balanced Approach to Patent Damages
AdvaMed, the Medtech Association, asked the United States Court of Appeals to support a fair and balanced approach to patent damages.
Legal
Learn more about our Legal work.
The End of Chevron Deference: What it Means for Medtech
The AdvaMed Code of Ethics on Interactions with Health Care Professionals in China – the “AdvaMed China Code” or “Code” – serves as a foundational charter for medical technology companies’…
Circuit Court Sides with Patient Safety and Medtech Innovators in Concluding that DMCA Exemptions are Subject to Judicial Review
In a decisive victory for medtech innovation, the D.C. Circuit Court of Appeals earlier this month held that the Digital Millennium Copyright Act (DMCA) regulations are judicially reviewable. Under this…
AdvaMed Applauds D.C. Circuit Decision Restoring Judicial Oversight to Rulemaking that Impacts Patient Care
Today, The Advanced Medical Technology Association (AdvaMed) commended the U.S. Court of Appeals for the District of Columbia Circuit’s decision in the case Medical Imaging & Technology Alliance and Advanced…
What Chevron’s Demise Could Mean for Medtech
The Supreme Court will soon address the fate of agency deference—an issue presented in Relentless v. Department of Commerce and Loper Bright Enterprises v. Raimondo—in a ruling expected to have…
Dark Money: Undisclosed Third Party Litigation Funding and Its Impact on Medical Technology
Third party litigation funding has become widespread in the civil justice system. The growing use of TPLF to generate mass tort litigation, particularly against manufacturers of medical technology, misuses the…
The Trial Bar’s Most Wanted: Breaking Down Litigation Trends and Themes Affecting Key Industries
Although the individual claims may differ, a review of recent products liability claims levied against industries targeted by the plaintiffs trial bar reveals common threads. For example, the drivers of…
MedTech Compliance Bootcamp
This carefully curated program will provide you with a comprehensive understanding of the current medtech compliance framework.
An Abuse of Justice: The Dark Side of Third-Party Litigation Financing
On September 13th, 2023, the U.S. House Oversight Committee held a hearing on the impact of third-party litigation financing, an issue of significant concern to AdvaMed and its members. Third-party…
AdvaMed Submits Letter to House Committee on Oversight and Accountability Concerning Third-Party Litigation Funding
Today, AdvaMed, the Medtech Association, submitted a letter to the House Committee on Oversight and Accountability regarding the Committee’s consideration of an issue that threatens to undermine the foundations of…